Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group

Published:2021-09-08 Issue:12 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Collier Anderson B.¹^ORCID,Krailo Mark D.²,Dang Ha M.²^ORCID,DuBois Steven G.³^ORCID,Hawkins Douglas S.⁴^ORCID,Bernstein Mark L.⁵,Bomgaars Lisa R.⁶,Reed Damon R.⁷^ORCID,Gorlick Richard G.⁸^ORCID,Janeway Katherine A.³^ORCID

Affiliation:

1. Department of Pediatrics University of Mississippi Medical Center Jackson Mississippi USA

2. Department of Preventive Medicine University of Southern California Los Angeles California USA

3. Dana‐Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School Boston Massachusetts USA

4. Department of Pediatrics Seattle Children's Hospital Seattle Washington USA

5. IWK Health Centre, Dalhousie University Port Williams Nova Scotia Canada

6. Department of Pediatrics Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center Houston Texas USA

7. Cancer Center and Blood Disorders Institute, Johns Hopkins All Children's Hospital St. Petersburg, Florida, USA and Department of Individualized Cancer Management, Moffitt Cancer Center Tampa Florida USA

8. MD Anderson Cancer Center, University of Texas Houston Texas USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29333

Reference20 articles.

1. Ewing's Sarcoma Family of Tumors: Current Management

2. Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial

3. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi‐modality therapy: A report from the Children's Oncology Group

4. Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

5. A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: A Children's Oncology Group study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials;Journal of Clinical Oncology;2024-09-01

2. Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board;Cancer;2024-08-25

3. Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma;Journal of Clinical Oncology;2024-07-02

4. Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group;Pediatric Blood & Cancer;2024-04-16

5. Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children’s Oncology Group;Cancer;2024-03-12